Abstract:Highlights • Sedanolide alleviated DSS-induced colitis by diminishing inflammation and strengthening the intestinal barrier. • Sedanolide reshaped the gut microbiota, especially decreased the BSH-expressing bacteria which resulted in the increased ratio of conjugated/unconjugated bile acids. • The altered bile acids profile due to sedanolide inhibited the intestinal FXR pathway, then increased the expression of SMPD3. • SMPD3-modulated accumulation of key ceramide (d18:1/16:0) mediated the protective effects of sedanolide. Introduction Inflammatory bowel disease (IBD) is a global disease with limited therapy. It is reported that sedanolide exerts anti-oxidative and anti-inflammatory effects as a natural phthalide, but its effects on IBD remain unclear. Objectives In this study, we investigated the impacts of sedanolide on dextran sodium sulfate (DSS)-induced colitis in mice. Methods The mice were administered sedanolide or vehicle followed by DSS administration, after which colitis symptoms, inflammation levels, and intestinal barrier function were evaluated. Transcriptome analysis, 16S rRNA sequencing, and targeted metabolomics analysis of bile acids and lipids were performed. Results Sedanolide protected mice from DSS-induced colitis, suppressed the inflammation, restored the weakened epithelial barrier, and modified the gut microbiota by decreasing bile salt hydrolase (BSH)-expressing bacteria. The downregulation of BSH activity by sedanolide increased the ratio of conjugated/unconjugated bile acids (BAs), thereby inhibiting the intestinal farnesoid X receptor (FXR) pathway. The roles of the FXR pathway and gut microbiota were verified using an intestinal FXR-specific agonist (fexaramine) and germ-free mice, respectively. Furthermore, we identified the key effector ceramide, which is regulated by sphingomyelin phosphodiesterase 3 (SMPD3). The protective effects of ceramide (d18:1/16:0) against inflammation and the gut barrier were demonstrated in vitro using the human cell line Caco-2. Conclusion Sedanolide could reshape the intestinal flora and influence BA composition, thus inhibiting the FXR-SMPD3 pathway to stimulate the synthesis of ceramide, which ultimately alleviated DSS-induced colitis in mice. Overall, our research revealed the protective effects of sedanolide against DSS-induced colitis in mice, which indicated that sedanolide may be a clinical treatment for colitis. Additionally, the key lipid ceramide (d18:1/16:0) was shown to mediate the protective effects of sedanolide, providing new insight into the associations between colitis and lipid metabolites. Graphical abstract Download : Download high-res image (144KB) Download : Download full-size image

Salidroside alleviates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota

Salidroside attenuates dextran sulfate sodium-induced colitis in mice via SIRT1/FoxOs signaling pathway.

The Abilities of Salidroside on Ameliorating Inflammation, Skewing the Imbalanced Nucleotide Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3/autophagy, and Maintaining Intestinal Barrier Are Profitable in Colitis

The Abilities of Salidroside on Ameliorating Inflammation, Skewing the Imbalanced NLRP3/Autophagy and Maintaining Intestinal Barrier Are Profitable in Colitis

Salvianolic Acid B Alters the Gut Microbiota and Mitigates Colitis Severity and Associated Inflammation

Salidroside Improves Antibiotic-Induced Gut Microbiota Disturbance and Low Levels of Short-Chain Fatty Acids in Mice

Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis-associated Th17/Treg imbalance

Chimonanthus salicifolius extract alleviates DSS‐induced colitis and regulates gut microbiota in mice

Salidroside Protects Mice from High-Fat Diet-Induced Obesity by Modulating the Gut Microbiota

Gut microbiota modulation and anti-inflammatory properties of mixed lactobacilli in dextran sodium sulfate-induced colitis in mice

Zeolite-containing Mixture Alleviates Microbial Dysbiosis in Dextran Sodium Sulfate-Induced Colitis in Mice

Protective Effects of Salvianolic Acid A against Dextran Sodium Sulfate-Induced Acute Colitis in Rats

Salidroside attenuates LPS-induced pro-inflammatory cytokine responses and improves survival in murine endotoxemia

Sedanolide alleviated DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice

Desmethylbellidifolin Attenuates Dextran Sulfate Sodium-Induced Colitis: Impact on Intestinal Barrier, Intestinal Inflammation and Gut Microbiota

The dietary supplement Rhodiola crenulata extract alleviates dextran sulfate sodium-induced colitis in mice through anti-inflammation, mediating gut barrier integrity and reshaping the gut microbiome

Sesamol Supplementation Attenuates DSS-Induced Colitis Via Mediating Gut Barrier Integrity, Inflammatory Responses, and Reshaping Gut Microbiome

Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis

SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice

Salvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis.

Salvia miltiorrhiza stems and leaves total phenolic acids combination with tanshinone protect against DSS-induced ulcerative colitis through inhibiting TLR4/PI3K/AKT/mTOR signaling pathway in mice